Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Belite Bio, Inc. Sponsored ADR (BLTE) had Weighted-Average Shares Outstanding (Diluted) of 32.08M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-14.28M |
|
-- |
|
-- |
|
$15.52M |
|
$-15.52M |
|
$1.24M |
|
$-14.28M |
|
$-14.28M |
|
$-14.28M |
|
$-14.28M |
|
$-14.28M |
|
$-14.28M |
|
$-15.52M |
|
$-15.52M |
|
32.08M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
32.08M |
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$159.29M |
|
-- |
|
$4.91M |
|
$164.20M |
|
-- |
|
-- |
|
-- |
|
$6.13M |
|
-- |
|
$158.07M |
|
$158.07M |
|
32.55M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.03% |
|
-8.69% |
|
-9.03% |
|
$4.86 |
|
-- |
|
-- |
|